We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Teva after

23 July 2015 By Reynolds Holding

The uniquely Dutch poison pill makes it likely that the drugmaker has seen off Teva’s $40 bln hostile bid. Mylan may now be able to seal a deal to buy smaller Perrigo. If not, Teva’s offer might re-emerge. Either way, though, investors have been deprived of a clear choice.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)